Imuthiol (Diethyldithiocarbamate)
Overview
Imuthiol is the sodium salt of diethyldithiocarbamate, a small molecule rather than a peptide, historically explored for immune modulation and antiviral properties. It is thought to alter cytokine profiles and scavenge reactive oxygen species. Therapeutic interest has focused on HIV infection and other states of immune dysregulation.
Key Research Findings
Early clinical trials in the late 1980s and early 1990s investigated imuthiol in HIV-positive patients, with some studies reporting transient increases in CD4 counts but no durable virologic or clinical benefit. Subsequent development was discontinued due to lack of efficacy in later-stage trials.
Intravenous, Oral
Investigational
Interested in Imuthiol (Diethyldithiocarbamate)?
Find a verified provider experienced with Imuthiol (Diethyldithiocarbamate) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Imuthiol (Diethyldithiocarbamate) ProviderRelated Peptides
Thymalin
InvestigationalA peptide bioregulator originally extracted from bovine thymus gland, consisting of a mixture of polypeptides that modulate immune function. Thymalin restores T-cell mediated immunity by promoting T-lymphocyte maturation and differentiation in the thymus. It also normalizes the ratio of T-helper to T-suppressor cells and enhances phagocytic activity of neutrophils and macrophages.
LL-37
Research PhaseThe only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide cleaved from the precursor protein hCAP18. LL-37 disrupts microbial membranes through electrostatic interactions and exerts broad-spectrum activity against bacteria, fungi, and enveloped viruses. Beyond direct antimicrobial effects, it modulates innate immunity by recruiting immune cells, promoting angiogenesis, and regulating inflammatory cytokine release.
VIP (Vasoactive Intestinal Peptide)
InvestigationalA 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems and immune cells. VIP acts through VPAC1 and VPAC2 receptors to produce potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-12) and promoting regulatory T-cell differentiation. It also functions as a vasodilator, bronchodilator, and neuromodulator.
Thymosin Alpha 1 (Zadaxin)
InvestigationalA 28-amino acid peptide originally isolated from thymic tissue (thymosin fraction 5) that serves as a potent immunomodulator. Thymosin alpha 1 enhances T-cell maturation, dendritic cell function, and antibody responses by activating Toll-like receptors (TLR2, TLR9) on innate immune cells. It promotes Th1 immune responses and augments vaccine efficacy while modulating inflammatory cytokine production.